OPTIMISE-CKD Study_Dapagliflozin Effectiveness in CKD

Clinical trial NCT07450820 · COMPLETED

Trial details

NCT number: NCT07450820
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Chronic Kidney Disease

Start date: 2026-02-18
Primary completion: 2026-05-06
Enrollment: 12894

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.